Skip to main content
Log in

The Cys allele (the Ser311Cys polymorphism) of the dopamine d2 receptor is associated with schizophrenia and impairments to selective attention in patients

  • Published:
Neuroscience and Behavioral Physiology Aims and scope Submit manuscript

We report here our studies of the Ser311Cys polymorphism of the D2 dopamine receptor gene in 366 patients with schizophrenia and 387 control subjects. The incidence of the Cys allele was found to be greater (p < 0.009) among patients than controls (8.5% and 3.9%, respectively). Selective attention was also studied on the basis of assessment of parameters of the P300 wave of auditory evoked potentials in 66 patients with different genotypes – SerSer and SerCys (the CysCys genotype was not seen among the patients). This revealed a significant influence of genotype (p = 0.01) on the latent period (LP) of the P300 wave in the frontal, central and temporal leads. In carriers of the Cys allele, which is associated with the risk of developing schizophrenia, LP was longer than in subjects with other genotypes, which is evidence for slowing of mental processes associated with activation of attention resources in these subjects. Thus, the results obtained here support data obtained previously for other populations showing that the Cys allele is associated with schizophrenia, and we also observed an association between this allele and degradation of selective attention in patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. M. V. Alfimova, L. G. Uvarova, and V. I. Trubnikov, “An evoked potentials method in studies of cognitive processes in schizophrenia,” Zh. Nevrol. Psikhiat., 99, No. 1, 62–68 (1999).

    CAS  Google Scholar 

  2. I. S. Lebedeva, V. G. Kaleda, L. I. Abramova, et al., “Neurophysiological anomalies in the P300 paradigm as possible endophenotypes of schizophrenia,” Zh. Nevrol. Psikhiat., 108, No. 1, 61–70 (2008).

    CAS  Google Scholar 

  3. T. Arinami, M. Itokawa, H. Enguchi, et al., “Association of dopamine D2 receptor molecular variant with schizophrenia,” Lancet, 343, No. 8899, 703–704 (1994).

    Article  CAS  PubMed  Google Scholar 

  4. K. Blum, E. R. Braverman, M. J. Dinardo, et al., “Prolonged P300 latency in a neuropsychiatric population with the D2 dopamine receptor A1 allele,” Pharmacogenetics, 4, No. 6, 313–322 (1994).

    Article  CAS  PubMed  Google Scholar 

  5. E. Bramon, C. McDonald, R. J. Croft, et al., “Is the P300 wave an endophenotype for schizophrenia? A meta-analysis and a family study,” Neuroimage, 27, No. 4, 960–968 (2005).

    Article  PubMed  Google Scholar 

  6. S. J. Glatt, S. V. Faraone, and M. T. Tsuang, “Meta-analysis identifies an association between the dopamine D2 receptor gene and schizophrenia,” Mol. Psychiat., 8, 911–915 (2003).

    Article  CAS  Google Scholar 

  7. S. J. Glatt and E. G. Jonsson, “The Cys allele of the DRD2 Ser311 polymorphism has a dominant effect on the risk for schizophrenia: evidence from fixed- and random-effects meta-analyses,” Am. J. Med. Genet. B. Neuropsychiat. Genet., 141, No. 2, 149–154 (2006).

    Article  Google Scholar 

  8. M. Houlihan, R. Stelmack, and K. Campbell, “P300 and cognitive ability: Assessing the roles of processing speed, perceptual processing demands and task difficulty,” Intelligence, 26, 9–25 (1998).

    Article  Google Scholar 

  9. M. Itokawa, T. Arinami, N. Futamura, et al., “A structural polymorphism of human dopamine D2 receptor, D2(Ser311>Cys),” Biochem. Biophys. Res. Commun., 196, No. 3, 1369–1375 (1993).

    Article  CAS  PubMed  Google Scholar 

  10. E. G. Jonsson, A. Sillen, M. Vares, et al., “Dopamine D2 receptor gene Ser311Cys variant and schizophrenia: association study and meta-analysis,” Am. J. Med. Genet., 119B, 28–34 (2003).

    Article  PubMed  Google Scholar 

  11. E. M. Meisenzahl, G. J. Schmitt, J. Scheurecker, and H.-J. Möller, “The role of dopamine for the pathophysiology of schizophrenia,” Int. Rev. Psychiat., 19, No. 4, 337–345 (2007).

    Article  CAS  Google Scholar 

  12. E. P. Noble, S. M. Berman, T. Z. Ozkaragoz, et al., “Prolonged P300 latency in children with the D2 dopamine receptor A1 allele,” Am. J. Hum. Genet., 54, No. 4, 658–668 (1994).

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to V. E. Golimbet.

Additional information

Translated from Zhurnal Nevrologii i Psikhiatrii imeni S. S. Korsakova, Vol. 109, No. 9, 67–70, September, 2009.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Golimbet, V.E., Lebedeva, I.S., Monakhov, M.V. et al. The Cys allele (the Ser311Cys polymorphism) of the dopamine d2 receptor is associated with schizophrenia and impairments to selective attention in patients. Neurosci Behav Physi 41, 22–25 (2011). https://doi.org/10.1007/s11055-010-9372-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11055-010-9372-7

Key Words

Navigation